Sex differences in tolerability and response to immune checkpoint inhibitors in non-small cell lung cancer patients

被引：0
|
作者：
Duma, Narjust [1 ]
Azzouqa, Abdel-Ghani [1 ]
Yadav, Siddhartha [1 ]
Hoversten, Kahterine [1 ]
Reed, Clay [1 ]
Sitek, Andrea [1 ]
Enninga, Elizabeth [1 ]
Paludo, Jonas [1 ]
Kottschade, Lisa [1 ]
Mansfield, Aaron [1 ]
Manochakian, Rami [1 ]
Dronca, Roxana [1 ]
Adjei, Alex [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2020年 / 29卷 / 06期
关键词：
D O I：
10.1158/1538-7755.DISP18-A120
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A120
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [31] Immune checkpoint inhibitors for patients with gene-rearranged non-small cell lung cancer
    Uehara, Yuji
    Hakozaki, Taiki
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (01) : 6 - 10
  • [32] Infectious Complications in Patients With Non-small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
    Guo, Matthew Z.
    Balaji, Aanika
    Murray, Joseph C.
    Reuss, Joshua E.
    Steinke, Seema Mehta
    Bennett, Kathleen
    Naidoo, Jarushka
    CLINICAL LUNG CANCER, 2023, 24 (07) : 613 - 620
  • [33] Re-administration of immune checkpoint inhibitors for patients with non-small cell lung cancer
    Hakozaki, Taiki
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022,
  • [34] Exploration of Factors Relating to Immune Response in Patients Treated with Immune Checkpoint Inhibitors for Non-small Cell Lung Cancer (NSCLC)
    Cardona, A. F.
    Arrieta, O.
    Ruiz-Patino, A.
    Zatarain Barron, L.
    Corrales-Rodriguez, L.
    Martin, C.
    Barron, F.
    Sotelo, C.
    Rodriguez, J.
    Ricaurte, L.
    Freitas, H.
    Cordeiro De Lima, V. C.
    Mas, L.
    Avila, J.
    Mayorga, D.
    Archila, P.
    Otero, J.
    Carranza, H.
    Vargas, C.
    Rosell, R.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1171 - S1171
  • [35] The impact of pre-treatment plasma sex hormones on the immune checkpoint inhibitors response in patients with metastatic non-small cell lung cancer
    Zhang, Y.
    Darville, L.
    Hogue, S.
    Johnson, J. Hallanger
    Kim, Y.
    Gray, J. E.
    Robinson, L.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1041 - S1041
  • [36] Peripheral monocytes and neutrophils predict response to immune checkpoint inhibitors in patients with metastatic non-small cell lung cancer
    Kaushal Parikh
    Arun Kumar
    Jibran Ahmed
    Asad Anwar
    Carmelo Puccio
    Hoo Chun
    Michael Fanucchi
    Seah H. Lim
    Cancer Immunology, Immunotherapy, 2018, 67 : 1365 - 1370
  • [37] Response to salvage chemotherapy following exposure to immune checkpoint inhibitors in patients with non-small cell lung cancer.
    Leger, Paul Denis
    Rothschild, Sasha
    Castellanos, Emily
    Pillai, Rathi Narayana
    York, Sally Jane
    Horn, Leora
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [38] Peripheral monocytes and neutrophils predict response to immune checkpoint inhibitors in patients with metastatic non-small cell lung cancer
    Parikh, Kaushal
    Kumar, Arun
    Ahmed, Jibran
    Anwar, Asad
    Puccio, Carmelo
    Chun, Hoo
    Fanucchi, Michael
    Lim, Seah H.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (09) : 1365 - 1370
  • [39] Clinical pattern of failure after a durable response to immune checkpoint inhibitors in non-small cell lung cancer patients
    Ja Yoon Heo
    Shin Hye Yoo
    Koung Jin Suh
    Se Hyun Kim
    Yu Jung Kim
    Chan-Young Ock
    Miso Kim
    Bhumsuk Keam
    Tae Min Kim
    Dong-Wan Kim
    Dae Seog Heo
    Jong Seok Lee
    Scientific Reports, 11
  • [40] Obesity, dyslipidemia, and diabetes as determinants of response to immune checkpoint inhibitors in non-small cell lung cancer
    Osataphan, Soravis Alm
    Awidi, Muhammad
    Jan, Yu Jen
    Sundararaman, Shriram
    Viray, Hollis
    Frankenberger, Edward
    Mariano, Melissa
    Stafford, Katherine Ann
    Kolnick, Aleksandra
    Ghazalah, Hind
    Patti, Mary-Elizabeth
    Gunturu, Krishna Soujanya
    Rangachari, Deepa
    Costa, Daniel Botelho
    Lam, Prudence B.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345